|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 263.55 EUR | +3.64% |
|
+3.89% | +10.21% |
| 06-25 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
| 06-22 | UBS Trims UCB's PT, Affirms Buy Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0.05% | +3.47% | +3.08% | -15.42% | -17.90% | +20.71% | -10.54% | +16.07% | +82.18% | 64.39B | ||
| +7.82% | +44.80% | +44.80% | +44.80% | +44.80% | +44.80% | +44.80% | +44.80% | - | 40.54B | ||
| +0.45% | -0.80% | +18.24% | -19.41% | -33.17% | -50.76% | -58.54% | -59.99% | +6.89% | 37.98B | ||
| +0.35% | +8.69% | +10.74% | +15.72% | +23.34% | +72.83% | -23.06% | -37.22% | -9.15% | 31.89B | ||
| +0.91% | +15.21% | +44.88% | +41.76% | +131.84% | +147.81% | -44.01% | -70.84% | - | 26.69B | ||
| -0.14% | +9.80% | +17.66% | +26.00% | +15.24% | +67.14% | +84.03% | +34.38% | +44.56% | 22.73B | ||
| +6.52% | +5.12% | +6.95% | -6.37% | +4.98% | +3.49% | +174.61% | -14.20% | - | 16.66B | ||
| -0.77% | +4.27% | +4.88% | +20.91% | +39.36% | +60.93% | +123.63% | +197.78% | +348.12% | 16.6B | ||
| +2.48% | +4.47% | +8.66% | +3.81% | -5.87% | +66.74% | +323.78% | +19.76% | - | 13.76B | ||
| -0.38% | -2.72% | +2.82% | +50.22% | +32.01% | +130.96% | +229.73% | +246.11% | +3,127.58% | 12.44B | ||
| +8.59% | +5.52% | +0.95% | -2.10% | -17.02% | -1.97% | +780.76% | +444.53% | +7,100.00% | 12B | ||
| -3.57% | +2.86% | +0.37% | +4.95% | -3.25% | +4.60% | -35.34% | -31.10% | -26.63% | 11.4B | ||
| -0.50% | +8.20% | +20.24% | +50.47% | +50.72% | +170.32% | +221.24% | +438.36% | - | 10.97B | ||
| -0.47% | +0.31% | -2.44% | +2.63% | -15.38% | -12.52% | -21.44% | -60.10% | -53.98% | 6.34B | ||
| -2.01% | +13.64% | +44.74% | +123.74% | +205.14% | +163.09% | +394.84% | -28.11% | - | 6.22B | ||
| +20.00% | +23.91% | +21.67% | +0.85% | +21.10% | +35.11% | +335.61% | +247.15% | - | 5.46B | ||
| +8.61% | +6.47% | +0.17% | -27.94% | -28.54% | -23.88% | +128.57% | +76.51% | +122.39% | 5.07B | ||
| +3.84% | -4.41% | -17.86% | -31.68% | -39.30% | -55.57% | -59.20% | -79.02% | - | 4.88B | ||
| +7.07% | +1.53% | +8.52% | -6.72% | -15.43% | +7.35% | +55.22% | -49.98% | - | 4.7B | ||
| Average | +3.10% | +5.24% | +12.58% | +14.54% | +20.67% | +44.80% | +139.19% | +70.26% | +1,074.20% | 18.46B | |
| Weighted average by Cap. | +2.12% | +6.00% | +15.89% | +12.14% | +17.87% | +43.62% | +77.98% | +42.78% | +616.28% |
- Stock Market
- Stocks
- UCB Stock
- UNC Stock
- Sector UCB
Select your edition
All financial news and data tailored to specific country editions
















